secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2025-02-03T23:59:59+00:00
Accession:  0001493152-25-004715
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences closes ~$5M public offering of stock and warrants
---------------------------------------------------------------------

- Gross proceeds ~$5M, net ~$4.3M from sale of 1.67M shares/pre-funded, Series A & B warrants at $3.00/unit.
- Series A warrants (5-yr, $3.00 strike) and Series B warrants (18-mo, $3.00 strike) are exercisable immediately.
- Proceeds earmarked for EB-003 development, working capital, and general corporate purposes.
- H.C. Wainwright acted as placement agent, receiving 7% cash fee plus warrants to purchase 116,666 shares at $3.75.
- Offering closed on February 3, 2025, with pre-funded warrants exercisable at $0.0001 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315225004715/0001493152-25-004715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315225004715/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer